PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
PANACEA LIFE SCIENCES HOLDINGS, INC.
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0004 (−0.57%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
PANACEA LIFE SCIENCES HOLDINGS, INC. grew revenue 50.4% to $2.76M over the twelve months to Mar 31, 2024. Free cash flow was -$1.59M.
Revenue
$2.76M
+50.4% vs. a year earlier
Operating income
-$5.31M
TTM Q1 2024
Free cash flow
-$1.59M
FY2023
EPS, diluted
-$0.46
TTM Q1 2024
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2024
Valuation
- Market cap
- $1.15M
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -138.50%
Fundamentals
- Revenue
- $2.76M
- Net income
- -$7.67M
- EPS, diluted
- -$0.46
- Free cash flow
- -$1.59M
- Book value per share
- -$0.58
- Diluted shares
- 16M
Eleven years at a glance
Fiscal years 2013 to 2023 and trailing twelve months, USD
Revenue
$2.76M+50.4% YoY
Gross profit
$1.56M+199.5% YoY
Operating income
-$5.31M
Net income
-$7.67M
EPS, diluted
-$0.46
Free cash flow
–
Reported periodTrailing twelve months